Moderna's Cancer Vaccine Shows Breakthrough Results in Trial

A personalized cancer vaccine from Moderna just aced its phase 3 trial for melanoma patients, marking a potential first for mRNA technology in cancer treatment.

The same company that brought us a COVID vaccine in record time could soon revolutionize how we fight cancer.